Patient | Diagnosis | Treatment plan parameter | ||
---|---|---|---|---|
Field width (cm) | Pitch | Modulation factor | ||
Non-TMI patients | ||||
P1 | Anaplastic oligodendroglioma | 2.5 | 0.43 | 2.20 |
P2 | Glioblastoma | 1.0 | 0.43 | 2.00 |
P3 | Glioblastoma | 1.0 | 0.41 | 2.20 |
P4 | Ca head of pancreas | 1.0 | 0.41 | 2.18 |
P5 | Oligometastatic Ca Lung | 1.0 | 0.43 | 2.35 |
P6 | Ca tongue recurrent | 1.0 | 0.41 | 2.35 |
P7 | Ca right breast | 2.5 | 0.28 | 2.40 |
P8 | Ca rectum post op | 2.5 | 0.43 | 2.00 |
P9 | Ca esophagus | 2.5 | 0.30 | 2.10 |
P10 | Meningioma | 1.0 | 0.41 | 1.90 |
TMI/TMLI patients | ||||
P11-HFS | Chronic myloid leukemia | 5.0 | 0.31 | 3.50 |
P11-FFS | 5.0 | 0.40 | 2.50 | |
P12-HFS | Acute lymphoblastic leukemia | 5.0 | 0.41 | 2.80 |
P12-FFS | 5.0 | 0.43 | 2.00 | |
P13-HFS | Acute lymphoblastic leukemia | 5.0 | 0.31 | 3.50 |
TP13-FFS | 5.0 | 0.41 | 2.40 | |
P14-HFS | Chronic myloid leukemia | 5.0 | 0.30 | 3.00 |
P14-FFS | 5.0 | 0.40 | 2.40 | |
P15-HFS | Acute lymphoblastic leukemia | 5.0 | 0.43 | 2.49 |
P15-FFS | 5.0 | 0.40 | 2.15 |